Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Merck
Baxter
Julphar
Teva

Generated: August 19, 2019

DrugPatentWatch Database Preview

Patent: 9,605,064

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,605,064
Title:Methods and compositions for treatment of skin disorders
Abstract: The invention provides methods and compositions for the treatment of a skin disorder associated with detrimental TNF.alpha. activity, such as psoriasis. The invention includes methods for treating a skin disorder associated with detrimental TNF.alpha. activity, such as psoriasis, in a subject who has failed or lost response to prior biologic therapy, such as prior administration of etanercept. The invention further provides methods for determining the efficacy of a human TNF.alpha. antibody, or antigen-binding portion thereof, for the treatment of a skin disorder associated with detrimental TNF.alpha. activity, such as psoriasis.
Inventor(s): Okun; Martin M. (Libertyville, IL), Hoffman; Rebecca S. (Wilmette, IL), Barker; Jonathan (London, GB)
Assignee: AbbVie Biotechnology Ltd (Hamilton, BM)
Application Number:12/859,181
Patent Claims:see list of patent claims

Details for Patent 9,605,064

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31   Try a Free Trial AbbVie Biotechnology Ltd (Hamilton, BM) 2026-04-10 RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31   Try a Free Trial AbbVie Biotechnology Ltd (Hamilton, BM) 2026-04-10 RX search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Try a Free Trial AbbVie Biotechnology Ltd (Hamilton, BM) 2026-04-10 RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chubb
Federal Trade Commission
US Department of Justice
Deloitte
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.